ACAD
Acadia Pharmaceuticals Inc. ยท Health Care ยท NASDAQ
$22.09
โฒ $0.47 (+2.17%)
Market cap
$3.7B
52-week range
$19.69 โ $28.35
Volume
1.9M
Previous close
$21.62
Acadia Pharmaceuticals Inc. (ACAD) is held by 2 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: BAKER BROS. ADVISORS LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
5.5% | 42.9M | $955M | โ | $18.82 | 2026-03-31 |
| RTW INVESTMENTS, LP RTW INVESTMENTS, LP |
1.6% | 7.1M | $159M | โ | $18.82 | 2026-03-31 |
FAQ โพ
Which hedge funds hold ACAD?
Tracked holders include: BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP.
How much smart money owns ACAD?
2 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading ACAD?
No tracked Congressional trades in ACAD on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.